|
XB-GENEPAGE-853991
Papers associated with pou2f1
???pagination.result.count???
???pagination.result.page??? ???pagination.result.prev??? 1 2
| Sort Newest To Oldest | Sort Oldest To Newest |
Histone acetylation characterizes chromatin presetting by NF1 and Oct1 and enhances glucocorticoid receptor binding to the MMTV promoter., Astrand C, Belikov S, Wrange O., Exp Cell Res. September 10, 2009; 315 (15): 2604-15. |
|
FoxA1 binding directs chromatin structure and the functional response of a glucocorticoid receptor-regulated promoter., Belikov S, Astrand C, Wrange O., Mol Cell Biol. October 1, 2009; 29 (20): 5413-25. |
|
Interaction of the multikinase inhibitors sorafenib and sunitinib with solute carriers and ATP-binding cassette transporters., Hu S, Chen Z, Franke R, Orwick S, Zhao M, Rudek MA, Sparreboom A, Baker SD., Clin Cancer Res. October 1, 2009; 15 (19): 6062-9. |
|
Dynamic regulation of Oct1 during mitosis by phosphorylation and ubiquitination., Kang J, Goodman B, Zheng Y, Tantin D., PLoS One. January 1, 2011; 6 (8): e23872.  |
|
The large extracellular loop of organic cation transporter 1 influences substrate affinity and is pivotal for oligomerization., Keller T, Egenberger B, Gorboulev V, Bernhard F, Uzelac Z, Gorbunov D, Wirth C, Koppatz S, Dötsch V, Hunte C, Sitte HH, Koepsell H., J Biol Chem. October 28, 2011; 286 (43): 37874-86. |
|
Transcription factors involved in lens development from the preplacodal ectoderm., Ogino H, Ochi H, Reza HM, Yasuda K., Dev Biol. March 15, 2012; 363 (2): 333-47.  |
|
Polyamine transport by the polyspecific organic cation transporters OCT1, OCT2, and OCT3., Sala-Rabanal M, Li DC, Dake GR, Kurata HT, Inyushin M, Skatchkov SN, Nichols CG., Mol Pharm. April 1, 2013; 10 (4): 1450-8. |
|
Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib., Herraez E, Lozano E, Macias RI, Vaquero J, Bujanda L, Banales JM, Marin JJ, Briz O., Hepatology. September 1, 2013; 58 (3): 1065-73. |
|
Cellular uptake of imatinib into leukemic cells is independent of human organic cation transporter 1 (OCT1)., Nies AT, Schaeffeler E, van der Kuip H, Cascorbi I, Bruhn O, Kneba M, Pott C, Hofmann U, Volk C, Hu S, Baker SD, Sparreboom A, Ruth P, Koepsell H, Schwab M., Clin Cancer Res. February 15, 2014; 20 (4): 985-94. |
|
Edoxaban transport via P-glycoprotein is a key factor for the drug's disposition., Mikkaichi T, Yoshigae Y, Masumoto H, Imaoka T, Rozehnal V, Fischer T, Okudaira N, Izumi T., Drug Metab Dispos. April 1, 2014; 42 (4): 520-8. |
|
Expression, sorting and transport studies for the orphan carrier SLC10A4 in neuronal and non-neuronal cell lines and in Xenopus laevis oocytes., Schmidt S, Moncada M, Burger S, Geyer J., BMC Neurosci. June 19, 2015; 16 35.  |
|
Retention of duplicated ITAM-containing transmembrane signaling subunits in the tetraploid amphibian species Xenopus laevis., Guselnikov SV, Grayfer L, De Jesús Andino F, Rogozin IB, Robert J, Taranin AV., Dev Comp Immunol. November 1, 2015; 53 (1): 158-68.  |
|
High-throughput analysis reveals novel maternal germline RNAs crucial for primordial germ cell preservation and proper migration., Owens DA, Butler AM, Aguero TH, Newman KM, Van Booven D, King ML., Development. January 15, 2017; 144 (2): 292-304.  |
|
In vitro and physiologically-based pharmacokinetic based assessment of drug-drug interaction potential of canagliflozin., Mamidi RNVS, Dallas S, Sensenhauser C, Lim HK, Scheers E, Verboven P, Cuyckens F, Leclercq L, Evans DC, Kelley MF, Johnson MD, Snoeys J., Br J Clin Pharmacol. May 1, 2017; 83 (5): 1082-1096. |
|
Comprehensive Substrate Characterization of 22 Antituberculosis Drugs for Multiple Solute Carrier (SLC) Uptake Transporters In Vitro., Parvez MM, Kaisar N, Shin HJ, Lee YJ, Shin JG., Antimicrob Agents Chemother. August 27, 2018; 62 (9): |
|
Imatinib Uptake into Cells is Not Mediated by Organic Cation Transporters OCT1, OCT2, or OCT3, But is Influenced by Extracellular pH., Blanc Mettral J, Faller N, Cruchon S, Sottas L, Buclin T, Schild L, Choong E, Nahimana A, Decosterd LA., Drug Metab Lett. January 1, 2019; 13 (2): 102-110. |
|
Sorafenib Activity and Disposition in Liver Cancer Does Not Depend on Organic Cation Transporter 1., Chen M, Neul C, Schaeffeler E, Frisch F, Winter S, Schwab M, Koepsell H, Hu S, Laufer S, Baker SD, Sparreboom A, Nies AT., Clin Pharmacol Ther. January 1, 2020; 107 (1): 227-237. |
|
In vitro modeling of cranial placode differentiation: Recent advances, challenges, and perspectives., Griffin C, Saint-Jeannet JP., Dev Biol. February 1, 2024; 506 20-30. |
???pagination.result.page??? ???pagination.result.prev??? 1 2